AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.

Biotechnology

Clinical Trials

Pharmaceutical

AdvanCell Isotopes Pty Ltd

Andrew Adamovich

Michael Tung

Sheruna Naidoo

Vanessa Worsfold

Thomas Kryza

Simon Puttick

Sheridan Martin

Nicolò Canever

Kevin Kuan

Julian F. Kelly

The Research and Development team at AdvanCell Isotopes Pty Ltd focuses on advancing the Targeted Alpha Therapy platform for cancer treatment. This team collaborates to innovate and enhance radiopharmaceuticals through rigorous scientific research, development of new materials, and ensuring ethical and safety compliance in preclinical studies.

Research and Development

Leadership Team

Research and Development

About

Team members

Other teams at AdvanCell Isotopes Pty Ltd

Leadership Team